UNSPSC 51286801: Chlorquinaldol

This classification denotes a topical anti-infective agent with the molecular formula C10H7Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D6VHC87LLS, chemically known as 5,7-dichloro-8-quinaldinol but more generally known as chlorquinaldol, which bears US NIH Compound Identifier 6301. European Medicines Agency schedules Chlorquinaldol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06211MIG. The term CHLORQUINALDOL is an International Non-Proprietary Name.

The World Health Organization schedules chlorquinaldol in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORQUINALDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=NC2=C(C=C1)C(=CC(=C2O)CL)CL.

UNSPSC 51286801 Chlorquinaldol, a Commodity code, nominally covers a single pharmaceutical ingredient, but recent state and local opportunities tagged under this code reflect a much broader procurement pattern: medical and pharmaceutical supply contracting that encompasses naloxone, drug deactivation systems, first-aid supplies, generic pharmaceuticals, and over-the-counter products. State and local governments use this code to solicit quantities ranging from hundreds to tens of thousands of units annually, delivered through established wholesaler networks or direct to health departments, fire departments, and community health facilities. Issuing bodies include county health departments, municipal fire services, state health and human services commissions, and cooperative purchasing alliances spanning multiple states. The work is transactional—sealed bids and RFPs for consumable medical supplies with firm pricing, delivery timelines typically measured in days to weeks, and contract terms of one to three years with renewal options. Set-asides and local business preferences appear selectively: the City of Tampa sheltered a $700,000 medical and first-aid supplies procurement exclusively for certified Small Local Business Enterprises with a 5 percent bid discount.

Recent activity clusters in Florida and Texas. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to its Community Health Building, response due July 26, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs and pharmacy benefit contracting strategies. The City of Tampa's Purchasing Department solicited medical and first-aid supplies (26P00145) through sealed bid in March 2026 for the Tampa Fire Department Rescue Division, estimated at $700,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota, Oregon, and other member states, with proposals due March 26, 2026. Cooperative purchasing vehicles appear frequently, suggesting economies of scale and standardized pricing are common drivers in this category.